Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab for Distal Lung Disease in Asthma
NCT00784485Phase 4Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in asthma, sponsored by University of California, Los Angeles. Started Feb 2009; status: terminated.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00784485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784485.